Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Q-Urol
- Development stage
- Phase 2
- Lead developer
- Farr Labs
- Modality
- Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Q-Urol is a multi-ingredient phytotherapeutic dietary supplement developed by Farr Laboratories for the management of chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS). The formulation contains a synergistic blend of quercetin, a bioflavonoid with potent antioxidant and anti-inflammatory properties; bromelain and papain, proteolytic enzymes that facilitate the absorption of quercetin and reduce tissue inflammation; and rye flower pollen extract (Cernitin), which has been shown to improve urinary flow and reduce pelvic pain. Q-Urol is designed to target the inflammatory and oxidative components of prostatic disease and has been evaluated in clinical trials, including studies on reducing the severity of radiation-induced prostatitis in patients undergoing brachytherapy for prostate cancer.
- Brand names
- Q-Urol
- Other names
- Quercetin + Bromelain + Rye Flower Pollen + Papain
02
Targets
NF-κBADRA1A (α1A)15-LOX (Lysyl Oxidase)COX
Beyond the preview
Go deeper on Q-Urol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Q-Urol.